UK biotech signs $230 million deal with Genentech
December 7, 2005Research and Development
UK biotech PIramed has signed a collaborative R&D deal with Genentech on a new class of cancer drugs, which could …
Research plans attract
December 7, 2005Sales and Marketing
Plans to boost UK medical research through improvements to NHS systems is set to attract an extra £1 billion investment …
CIPR to debate impact of new prescribers
December 7, 2005The CIPR Health & Medical Group will debate the new prescribing powers proposed for nurses and pharmacists at a special …
Rx Award wins for Paling Walters and LEC Advertising
December 7, 2005Medical Communications
Paling Walters and Lane Earl & Cox won prestigious awards at New York's Rx Club Awards.The agency's Lethal obsession campaign …
Communicating with patients
December 5, 2005Sales and Marketing
Despite little prospect of the restrictions in Europe on communicating directly with consumers being relaxed, the issue of DTC communications …
New UK headquarters for Bristol-Myers Squibb
December 5, 2005Sales and Marketing BMS, UK
Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …
Merck plans diabetes compliance campaign
December 5, 2005Medical Communications
Merck Pharmaceuticals has engaged Medicom to improve compliance in diabetic patients as part of the communications strategy for its type …
Sanofi-Aventis throws its weight behind Acomplia
December 5, 2005Sales and Marketing
Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …
Scheuble quits as Merck KGaA chief
December 5, 2005Sales and Marketing
Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …
58,000 people living with HIV in the UK
December 5, 2005The number of people living with HIV in the UK is now more than 58,000 – including nearly 20,000 who …
GlaxoSmithKline’s lapatinib hailed as latest ‘wonder drug’
December 1, 2005Sales and Marketing
GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …
Altana and Serono seeking mergers
November 30, 2005Sales and Marketing
Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …
Pfizer critical of generic plan for three million statin patients
November 30, 2005More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …
Pfizer’s new anti-smoking drug shows promise
November 29, 2005Sales and Marketing
Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …
Pharma unprepared for shift to secondary care
November 28, 2005Research and Development
Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
AstraZeneca fights generic Nexium bid
November 25, 2005Sales and Marketing
AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …
Which company has the industry’s best R&D pipeline?
November 25, 2005Sales and Marketing
Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …
Chiron to make up shortfall in UK flu vaccine
November 25, 2005Manufacturing and Production
Chiron has agreed to help the UK government make up a shortfall in flu vaccine supplies by producing an extra …
PR as important as salesforces, say marketers
November 24, 2005Medical Communications
A new survey of the UK pharmaceutical industry has found PR is considered just as important to marketing efforts as …
FDA clears Tamiflu in children after safety scare
November 22, 2005Sales and Marketing
The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …
Latest content
FibroFind appoints Lee Borthwick as CEO
